Keywords
сancer, oncology, cardio-oncology, arrhythmia, corrected QT interval
Abstract
Cardiovascular disease and cancer are the top causes of illness and death around the world. Despite the progress in cancer treatment, ventricular arrhythmias (VA) remain a significant cardiovascular complication caused by traditional and new cancer treatments. Understanding this issue is crucial for optimizing patient care. This review will discuss ventricular conduction (QRS) and repolarization abnormalities (QTc prolongation) associated with cancer therapies, as well as strategies for identifying, preventing, and managing cancer-treatment-induced vascular issues.